|Day's Range||4.26 - 4.38|
|52 Week Range||3.95 - 8.35|
|PE Ratio (TTM)||6.40|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Mississauga, Ontario-based company said it had profit of 14 cents per share. The drugmaker posted revenue of $5.3 million in the period. In the final minutes of trading on Wednesday, the company's ...
On a per-share basis, the Mississauga, Ontario-based company said it had net income of 11 cents. The drugmaker posted revenue of $4.2 million in the period. For the year, the company reported net income ...
Categories: Yahoo Finance Get free summary analysis Nuvo Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Nuvo Pharmaceuticals, Inc. – Valeant Pharmaceuticals International Inc, Theratechnologies Inc., Cipher Pharmaceuticals Inc. and BELLUS Health Inc. (VRX-CA, TH-CA, CPH-CA and BLU-CA) that have also reported for this ... Read more (Read more...)